Issue 4, 2024

Tailoring lipid nanoparticle dimensions through manufacturing processes

Abstract

Lipid nanoparticles (LNPs), most commonly recognised for their role in COVID-19 mRNA vaccines, are important delivery vehicles for nucleic acid (mRNA, siRNA) therapies. The physicochemical attributes, such as size, nucleic acid encapsulation and electric charge, may have a significant impact on the efficacy of these medicines. In this study, adjustments to aqueous to lipid phase ratios were assessed for their impact on LNP size and other critical quality attributes (CQAs). It was observed that minor adjustments of aqueous-to-organic lipid phase ratios can be used to precisely control the size of ALC-0315-formulated LNPs. This was then used to evaluate the impact of phase ratio and corresponding size ranges on the in vitro and in vivo expression of these LNPs. In HEK293 cells, larger LNPs led to higher expression of the mRNA cargo within the LNPs, with a linear correlation between size and expression. In THP-1 cells this preference for larger LNPs was observed up to 120 d.nm after which there was a fall in expression. In BALB/c mice, however, LNPs at the lowest phase ratio tested, >120 d.nm, showed reduced expression compared to those of range 60–120 d.nm, within which there was no significant difference between sizes. These results suggest a robustness of LNP expression up to 120 d.nm, larger than those <100 d.nm conventionally used in medicine.

Graphical abstract: Tailoring lipid nanoparticle dimensions through manufacturing processes

Supplementary files

Article information

Article type
Paper
Submitted
29 Apr 2024
Accepted
29 Aug 2024
First published
23 Sep 2024
This article is Open Access
Creative Commons BY license

RSC Pharm., 2024,1, 841-853

Tailoring lipid nanoparticle dimensions through manufacturing processes

C. McMillan, A. Druschitz, S. Rumbelow, A. Borah, B. Binici, Z. Rattray and Y. Perrie, RSC Pharm., 2024, 1, 841 DOI: 10.1039/D4PM00128A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements